Market Overview:
The global implantable heart pacemaker market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of heart diseases, technological advancements in implantable heart pacemakers, and rising geriatric population. Based on type, the global implantable heart pacemaker market is segmented into temporary and permanent implants. The temporary implants segment is further sub-segmented into single chamber and dual chamber devices. The permanent implants segment is further sub-segmented into single lead and dual lead devices. Based on application, the global implantable heart pacemaker market is divided into four segments: Heart block, sick sinus syndrome (SSS), diagnosing heart diseases, and others (including atrial fibrillation (AF) & congestive cardiac failure (CCF)). In terms of geography, the global implantable heart pacemaker market has been classified into five regions: North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
An implantable heart pacemaker is a battery-operated device that sends electrical impulses to your heart muscles to help them beat in a regular rhythm. An implantable heart pacemaker is important because it can help improve your quality of life if you have an irregular heartbeat.
Temporary:
Temporary pacemakers are used in patients suffering from bradycardia or heart blockage. They serve the purpose of pacing and synchronization of the heartbeat. These devices are implanted for a temporary period, until permanent pacemaker is ready for delivery.
Permanent:
Permanent pacemakers are used to treat bradycardia and heart block. They are also useful in the treatment of sinus node dysfunction, slow heart rate, and prolongation of QT interval. The most common type is the pace maker or permanent pacemaker which is implanted inside the body. It works by contracting and relaxing certain muscles which cause a regular heartbeat without any intervention from the patient’s conscious mind.
Application Insights:
The heart block segment dominated the global implantable heart pacemaker market in terms of revenue share in 2017. The high prevalence of atrial fibrillation and flutter is one of the major factors contributing to the large share held by this segment. As per a research study published in 2019, almost 40% patients with atrial fibrillation are receiving permanent cardiac pacemakers as compared to around 25% who have normal hearts.
Sick sinus syndrome is expected to be the fastest-growing application segment during forecast years due to increasing awareness about treatment options for this condition and growing number of surgical procedures performed for its treatment. According to a research study published in 2019, nearly 60% patients suffering from sick sinus syndrome were referred by primary care physicians owing to symptoms such as facial pain along with congestion & cough, which didn't respond wellto medical treatments or antibiotics prescribed by doctors.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large patient pool, favorable reimbursement policies, and high healthcare expenditure levels in this region. Moreover, technological advancements such as long battery life and wireless remote monitoring are further expected to drive growth during the forecast period. Europe is also estimated to witness significant growth over the coming years due to its well-developed healthcare infrastructure along with rising geriatric population prone to various cardiac diseases.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising awareness about the benefits of implantable heart pacemakers
- Technological advancements in implantable heart pacemaker devices
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Heart Pacemaker Market Research Report
By Type
Temporary, Permanent, Others
By Application
Heart Block, Sick Sinus Syndrome, Diagnosing Heart Diseases, Others
By Companies
Medtronic, Biotronik, Boston Scientific Corporation, St. Jude Medical, ZOLL Medical Corporation, Medico S.p.A, Vitatron, Pacetronix, Sorin Group, Cordis, Inc, Neuroiz, Abbott, Shree Pacetronix, Cook Medical, Izhevsky Mekhanichesky Zavod, CCC Medical Devices, Pacetronix, Cardioelectronica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Heart Pacemaker Market Report Segments:
The global Implantable Heart Pacemaker market is segmented on the basis of:
Types
Temporary, Permanent, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Block, Sick Sinus Syndrome, Diagnosing Heart Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Biotronik
- Boston Scientific Corporation
- St. Jude Medical
- ZOLL Medical Corporation
- Medico S.p.A
- Vitatron
- Pacetronix
- Sorin Group
- Cordis, Inc
- Neuroiz
- Abbott
- Shree Pacetronix
- Cook Medical
- Izhevsky Mekhanichesky Zavod
- CCC Medical Devices
- Pacetronix
- Cardioelectronica
Highlights of The Implantable Heart Pacemaker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Temporary
- Permanent
- Others
- By Application:
- Heart Block
- Sick Sinus Syndrome
- Diagnosing Heart Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Heart Pacemaker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An implantable heart pacemaker is a small, battery-operated device that is surgically placed under the skin in the chest. The pacemaker sends electrical impulses to the heart to keep it beating normally.
Some of the major companies in the implantable heart pacemaker market are Medtronic, Biotronik, Boston Scientific Corporation, St. Jude Medical, ZOLL Medical Corporation, Medico S.p.A, Vitatron, Pacetronix, Sorin Group, Cordis, Inc, Neuroiz, Abbott, Shree Pacetronix, Cook Medical, Izhevsky Mekhanichesky Zavod, CCC Medical Devices, Pacetronix, Cardioelectronica.
The implantable heart pacemaker market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Heart Pacemaker Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Heart Pacemaker Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Heart Pacemaker Market - Supply Chain
4.5. Global Implantable Heart Pacemaker Market Forecast
4.5.1. Implantable Heart Pacemaker Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Heart Pacemaker Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Heart Pacemaker Market Absolute $ Opportunity
5. Global Implantable Heart Pacemaker Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Heart Pacemaker Market Size and Volume Forecast by Type
5.3.1. Temporary
5.3.2. Permanent
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Heart Pacemaker Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Heart Pacemaker Market Size and Volume Forecast by Application
6.3.1. Heart Block
6.3.2. Sick Sinus Syndrome
6.3.3. Diagnosing Heart Diseases
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Heart Pacemaker Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Heart Pacemaker Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Heart Pacemaker Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Heart Pacemaker Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Heart Pacemaker Demand Share Forecast, 2019-2026
9. North America Implantable Heart Pacemaker Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Heart Pacemaker Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Heart Pacemaker Market Size and Volume Forecast by Application
9.4.1. Heart Block
9.4.2. Sick Sinus Syndrome
9.4.3. Diagnosing Heart Diseases
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Heart Pacemaker Market Size and Volume Forecast by Type
9.7.1. Temporary
9.7.2. Permanent
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Heart Pacemaker Demand Share Forecast, 2019-2026
10. Latin America Implantable Heart Pacemaker Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Heart Pacemaker Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Heart Pacemaker Market Size and Volume Forecast by Application
10.4.1. Heart Block
10.4.2. Sick Sinus Syndrome
10.4.3. Diagnosing Heart Diseases
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Heart Pacemaker Market Size and Volume Forecast by Type
10.7.1. Temporary
10.7.2. Permanent
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Heart Pacemaker Demand Share Forecast, 2019-2026
11. Europe Implantable Heart Pacemaker Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Heart Pacemaker Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Heart Pacemaker Market Size and Volume Forecast by Application
11.4.1. Heart Block
11.4.2. Sick Sinus Syndrome
11.4.3. Diagnosing Heart Diseases
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Heart Pacemaker Market Size and Volume Forecast by Type
11.7.1. Temporary
11.7.2. Permanent
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Heart Pacemaker Demand Share, 2019-2026
12. Asia Pacific Implantable Heart Pacemaker Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Heart Pacemaker Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Heart Pacemaker Market Size and Volume Forecast by Application
12.4.1. Heart Block
12.4.2. Sick Sinus Syndrome
12.4.3. Diagnosing Heart Diseases
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Heart Pacemaker Market Size and Volume Forecast by Type
12.7.1. Temporary
12.7.2. Permanent
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Heart Pacemaker Demand Share, 2019-2026
13. Middle East & Africa Implantable Heart Pacemaker Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Heart Pacemaker Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Heart Pacemaker Market Size and Volume Forecast by Application
13.4.1. Heart Block
13.4.2. Sick Sinus Syndrome
13.4.3. Diagnosing Heart Diseases
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Heart Pacemaker Market Size and Volume Forecast by Type
13.7.1. Temporary
13.7.2. Permanent
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Heart Pacemaker Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Implantable Heart Pacemaker Market: Market Share Analysis
14.2. Implantable Heart Pacemaker Distributors and Customers
14.3. Implantable Heart Pacemaker Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biotronik
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. St. Jude Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ZOLL Medical Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medico S.p.A
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Vitatron
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pacetronix
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sorin Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cordis, Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Neuroiz
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Abbott
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Shree Pacetronix
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cook Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Izhevsky Mekhanichesky Zavod
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. CCC Medical Devices
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Pacetronix
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Cardioelectronica
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
